Fulvestrant
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-317 -
Package NDC
68462-317-32 -
Application number
ANDA207754 -
SPL ID
e98586b1-cab4-4f10-bf04-7e92f3ca2ff2 -
SPL set ID
99cf8b69-4c23-4886-80e9-b23e348b5bd7 -
UNII
22X328QOC4 -
RxCUI
727762
What the source publishes
- Labeler
- GLENMARK PHARMACEUTICALS INC., USA
- Active ingredients
- Fulvestrant
- Form
- INJECTION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Fulvestrant",
"splId": "e98586b1-cab4-4f10-bf04-7e92f3ca2ff2",
"labels": [
{
"setId": "99cf8b69-4c23-4886-80e9-b23e348b5bd7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99cf8b69-4c23-4886-80e9-b23e348b5bd7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=99cf8b69-4c23-4886-80e9-b23e348b5bd7"
}
],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "GLENMARK PHARMACEUTICALS INC., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 SYRINGE, GLASS in 1 CARTON (68462-317-32) / 5 mL in 1 SYRINGE, GLASS (68462-317-40)",
"package_ndc": "68462-317-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20190822"
}
],
"productId": "68462-317_e98586b1-cab4-4f10-bf04-7e92f3ca2ff2",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "68462-317",
"deaSchedule": null,
"genericName": "Fulvestrant",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "FULVESTRANT",
"strength": "50 mg/mL"
}
],
"applicationNumber": "ANDA207754",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190822",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175582",
"N0000000145",
"N0000000168"
],
"unii": [
"22X328QOC4"
],
"rxcui": [
"727762"
],
"spl_set_id": [
"99cf8b69-4c23-4886-80e9-b23e348b5bd7"
],
"pharm_class_epc": [
"Estrogen Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Estrogen Receptor Antagonists [MoA]",
"Selective Estrogen Receptor Modulators [MoA]"
],
"manufacturer_name": [
"GLENMARK PHARMACEUTICALS INC., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-317_e98586b1-cab4-4f10-bf04-7e92f3ca2ff2"